Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Discover

Markets

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Policy Data rights Terms of Use Feedback Cookie Policy Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

— 2hHanmi Genentech obesity drug deal worth $2.3B reportedHanmi Pharmaceutical has signed an exclusive, worldwide license with Genentech for HM17321, a long-acting UCN2 analog aimed at obesity that promises weight loss with muscle preservation, with Genentech taking over development from Phase 2 onward outside Korea. The deal could reach about $2.3 billion, including a $190 million upfront, up to $2.1 billion in milestones, and future royalties, subject to U.S. antitrust clearance and successful clinical progression.14 sources · 2h

Finance — 6dEmpowered Funds Buys 55,463 Theravance SharesTheravance Biopharma has drawn notable institutional interest in Q1, with Empowered Funds and other firms expanding positions as institutional ownership remains dominant, while analysts view TBPH favorably against Ayala Pharmaceuticals with a roughly $19.40 price target. The company’s pending sale to Zymeworks for $17 per share is now the subject of an investor-protection probe by Halper Sadeh LLP, which is examining whether the deal process fairly maximized value for shareholders.5 sources · 6d

— Aug 17, 2026Hyundai Hope on Wheels expands cancer survivorship scaleA broad push in cancer research has driven pediatric survival gains through substantial funding and FDA-approved therapies, while public understanding of survivorship remains mixed and the long-term needs of survivors persist. At the same time, preclinical work combining radiopharmaceuticals with CAR T-cell therapy shows promise for neuroblastoma, and specialized fellowships in Canada are expanding clinical and translational opportunities in lung cancer research.6 sources · Aug 17, 2026

— Jul 27, 2026Sofdra growth drives Botanix Q4 FY26 update, record June shipmentsBotanix Pharmaceuticals reports accelerating Sofdra adoption in Q4 FY26, with prescriptions up 25% to 33,358 and a June monthly peak of 12,895, alongside $46.7 million in gross sales and a $10.1 million net revenue, aided by a improving gross-to-net yield of 22%. The company is trimming costs, expanding its API supplier base, fortifying its IP position, and narrowing operating cash burn as it strengthens its US market focus and dual US-Australia business footprint to support sustainable growth.5 sources · Jul 27, 2026

IJR1984 Has Arrived, And People Are Fighting BackDaily Caller News Foundation · 8 min · Jul 17, 2026

Business — Jul 26, 2026Insurers, Medical Stocks Rally Ahead of EarningsFrom penny-stock hopefuls like Vizsla Silver and Clover Health to heavyweight medical names such as Danaher, Intuitive Surgical and Eli Lilly, investors are weighing high-growth potential against execution risk as volumes, profitability, and catalysts drive attention. Insurance stocks Cincinnati Financial, Reinsurance Group of America, Oscar Health, Willis Towers Watson and Aflac are poised to outperform, while Custom Health Holdings’ bid for Evergreen Pharmacy and Alnylam Pharmaceuticals’ RNAi-focused pipeline illustrate ongoing deal activity and biotech risk-reward in a rate-sensitive, geopolitically unsettled market.15 sources · Jul 26, 2026

RankingMost underrated cities in AmericaAmerica's biggest cities hog all the spotlight, while dozens of smaller gems get overlooked despite great food, culture, and character. These underrated cities deserve recognition beyond the usual coastal favorites. Cast your vote and help crown the most underappreciated city in the country.693 votes · 21 candidates

— Jul 25, 2026Tariffs on U.S. Generics Could Reshape Supply ChainsPresident Donald Trump unveiled a phased tariff plan for imported generic drugs, imposing a zero tariff for two years starting August 1, 2026, then escalating to 100% for one year and 200% thereafter to push onshoring of U.S. production and penalize companies that don’t build domestic facilities. The move expands the administration’s pharmaceutical trade policy after an earlier Section 232 action and signals potential broader application beyond generics to reshape drug supply chains.246 sources · Jul 25, 2026

— Jul 24, 2026Coupang Expands Incheon Fire Relief Offers Health ChecksCoupang Fulfillment Services unveiled a comprehensive relief package for residents affected by the Incheon warehouse fire, offering free health checkups, reimbursement for medical and pharmaceutical costs, and coverage of cleaning and car-wash expenses, with professional damage assessors available free of charge. A temporary clinic at Sinhyeon Elementary School will run July 25–August 7, staffed by about 20 medical professionals, and a dedicated Incheon Fire Relief Call Center will operate July 27–November 30 to verify and process claims, including support for nearby factories and small businesses facing vehicle restrictions.7 sources · Jul 24, 2026

— Jul 23, 2026Akums plans acquisition of Oriflame India's manufacturing assetsAkums Drugs and Pharmaceuticals will acquire Oriflame India's manufacturing business for ₹56 crore through its subsidiary Pure and Cure Healthcare, gaining two plants in Roorkee and Noida plus a Noida warehouse and immediate capacity to produce skincare, haircare, and color cosmetics as it diversifies beyond pharmaceutical manufacturing, with completion expected by August 31, 2026. The move signals a strategic shift into the fast-growing beauty and personal care sector and could open opportunities for both domestic and export opportunities leveraging Halal certifications and European machinery.5 sources · Jul 23, 2026

— Jul 23, 2026India pharma deals hold steady at $13.9BIndian pharma and healthcare deal value held at about $13.9 billion in Q1 FY27 and Q2 2026 despite a decline in deal volumes, led by Sun Pharmaceutical Industries’ $11.8 billion acquisition of Organon & Co. and a clear shift toward specialty portfolios, global market access, and differentiated capabilities, with investor interest centering on AI-enabled care, genomics, oncology, and advanced diagnostics, and outbound M&A accounting for the vast majority of activity.5 sources · Jul 23, 2026

On X · @BEFIRSTofficialBE:FIRST Opens Dedicated “Missing” Station Livestream on Official YouTube ChannelThe official BE:FIRST account announced the launch of a YouTube livestream called ”BE:FIRST 'Missing' Station”, focused on their track “Missing,” allowing fans (BESTY) to stream and celebrate the song together in real time. The post gained traction primarily as a surprise fan-engagement drop.1,770 likes · 26m

— Jul 22, 2026LB Pharmaceuticals accelerates Phase 3 NOVA-2 timeline across 25 U.S. sites, targets 1H 2027 toplineLB Pharmaceuticals now expects topline results from the Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027, ahead of prior guidance, with a planned pre-NDA FDA meeting in the second half of 2027. The company highlights faster enrollment across about 460 patients at 25 U.S. sites, possible open-label extension and ongoing Phase 2 studies in bipolar depression and major depressive disorder, plus a cash runway into 2029 to support multiple readouts.6 sources · Jul 22, 2026

— Jul 22, 2026Trump tariffs hit Indian pharma stocksIndian pharmaceutical stocks slid after US President Donald Trump unveiled a phased tariff plan for imported generic medicines, offering a two-year zero-tariff window beginning August 1, 2026, followed by 100% tariffs from August 2028 and 200% from August 2029, fueling concerns about US-facing revenue for Indian drugmakers. The move dragged the Nifty Pharma index and major exporters like Sun Pharma, Cipla and Dr Reddy’s lower as investors reassess long-term earnings amid the policy shift.13 sources · Jul 22, 2026

VS BattleJim Carrey vs Adam SandlerRubber-faced mania versus deadpan slob comedy — two 90s comedy titans, two entirely different engines.Jim Carrey vs Adam Sandler · 146 votes — pick a side

Business — Jul 22, 2026Cathay Pacific Sees 1H Profit Jump to HK$6.5BCathay Pacific forecasts first-half profit of HK$6-6.5 billion, up from HK$3.7 billion a year earlier, aided by strong passenger and cargo demand and a HK$1.4 billion gain from the dilution of its Air China stake. Despite elevated fuel costs from Middle East tensions, the carrier benefited from rerouted travel, robust cargo including AI and pharmaceutical shipments, and fuel hedging and surcharges to cushion margins.6 sources · Jul 22, 2026

Business — Jul 21, 2026Telix Q2 Revenue Up 21% to $247MTelix Pharmaceuticals reported US$247 million in Q2 2026 group revenue, up 21% year over year and 7% quarter over quarter, with the Precision Medicine unit delivering US$202 million and leading growth. The company reaffirmed FY2026 guidance to exceed US$1 billion, supported by a US$40 million Regeneron inflow, FDA alignment for TLX591-Tx Phase 3, progress in the BiPASS pre-biopsy program, and ongoing manufacturing expansions and strategic initiatives with Regeneron.6 sources · Jul 21, 2026

— Jul 2, 2026Pfizer Reaches Agreement With Trump on Drug PricesA deal between Pfizer and former President Donald Trump is sending shockwaves through both the healthcare industry and Washington — and not everyone saw it coming. Pfizer, one of the largest pharmaceutical companies in…1 source · Jul 2, 2026

Trending NewsfeedHigh School Coach Exonerated After Years, $350k In Legal FeesA defamation lawsuit involving Fresno Unified School District trustee Keshia Thomas has intensified after new statements raised questions about a racial-slur allegation she made against a former Bullard High School football coach. Thomas is being sued by former Bullard coach and teacher Don Arax, who says she falsely accused him of using the N-word toward her son. The dispute dates back to comment9h

— Jul 2, 2026Ex-FDA Commissioners Against Higher Vaccine Standards Took $6 Million From COVID Vaccine MakersTen of the twelve former Food and Drug Administration (FDA) commissioners and acting commissioners opposed to the Trump administration’s stiffer standards for vaccines quietly disclosed ties to the pharmaceutical…1 source · Jul 2, 2026

QuizThe Big FiveThe personality model scientists actually use — five traits, twenty questions, your real percentages, and an AI read of what your mix means.4 min · today's quiz

— Jul 2, 2026Trump Announces $250 Weight Loss Drugs In Latest ‘TrumpRx’ DealPresident Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and Novo Nordisk in a Thursday Oval Office announcement. The obesity drugs Zepbound, marketed by…1 source · Jul 2, 2026

— Jul 2, 2026SCOOP: Tylenol Maker Privately Admitted Evidence Was Getting ‘Heavy’ For Autism Risk In 2018The pharmaceutical company behind Tylenol privately acknowledged the likelihood of an association between its drug in pregnancy and neurodevelopmental disorders like autism in children seven years ago, company documents…1 source · Jul 2, 2026

— Jul 2, 2026Trump Cracks Down On Big Pharma TV Ads But Does Not Ban ThemPresident Donald Trump signed a memorandum Tuesday directing the Food and Drug Administration (FDA) to crack down on deceptive pharmaceutical ads on television and social media. The FDA will simultaneously ship 100…1 source · Jul 2, 2026

— Jul 2, 2026RFK Jr. Accuses Elizabeth Warren Point-Blank Of Being Shill For Big PharmaHealth and Human Services (HHS) Secretary Robert F. Kennedy Jr. on Thursday accused Democratic Massachusetts Sen. Elizabeth Warren of taking major contributions from pharmaceutical companies. Warren received $818,997…1 source · Jul 2, 2026

IJRNew York First To Blink In Icy Staredown Against Data CentersDaily Caller News Foundation · 3 min · Jul 17, 2026

Reporting — Jul 1, 2026‘Our Country Will Finally Be Treated Fairly’: Trump Signs ‘Aggressive’ Executive Order Slashing Drug PricesPresident Donald Trump signed an executive order Monday that he said will slash drug prices by approximately 59% or more and end global freeloading off of American investments in pharmaceutical research and development…1 source · Jul 1, 2026

Reporting — Jul 1, 2026New Tool Lets You Search CDC Advisors’ Big Pharma TiesA new search tool unveiled Friday increases public access to information about the connections between advisors to the Centers for Disease Control and Prevention on vaccine policy and the pharmaceutical industry. The…1 source · Jul 1, 2026

Reporting — Jul 1, 2026RFK’s Calls To Ban One Of Big Pharma’s Most Powerful Tools Rattle Drugmakers Despite Uncertain Political ProspectsPresident-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to helm the Department of Health and Human Services(HHS) is reportedly rattling drugmakers in light of Kennedy’s prior calls to ban pharmaceutical…1 source · Jul 1, 2026

Reporting — Jul 1, 2026Pharma Stocks Take Nose Dive After Trump Announces RFK Jr. For HHSThe stocks for three pharmaceutical companies heavily involved in the production of vaccines fell drastically by market close on Thursday following President-elect Donald Trump’s announcement that he was appointing…1 source · Jul 1, 2026

Reporting — Jul 1, 2026‘It Doesn’t Affect Me’: Trump Reveals Who Wasn’t ‘Thrilled’ About His Team Up With RFK Jr.Former President Donald Trump told podcaster Joe Rogan that pharmaceutical executives were not “thrilled” that he teamed up with former independent presidential candidate Robert F. Kennedy Jr. during a Friday interview…1 source · Jul 1, 2026

On X · @YX_LABELS&TEAM CRAVE YOU Concept PhotosOverwhelmingly positive fan reactions to &TEAM's KR mini album concept photos featuring EJ and Nicholas, with strong excitement around visuals and pairings but no opposition.2,260 likes · 26m